Drug development
and diagnostics

Choose the relevant keywords from the list to search for research groups on those specific areas. As the search is cumulative, choose only a few keywords for a general search and more keywords for more refined search. To see all research groups, click the selection underneath the list.

Clear All
All research groups

Research Groups and R&D Platforms: Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care

Research Group:
Prognostic features in triple-negative breast carcinoma

Pauliina Kronqvist
paukro[at]utu.fi

Institute of Biomedicine,
University of Turku

Pauliina Kronqvist

Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care

Further information

Pauli Ollikka, Project Coordinator

pauli.ollikka@abo.fi
pauli.ollikka@utu.fi

Drug development and diagnostics is a common research profiling area of the University of Turku and Åbo Akademi University funded by the Academy of Finland. This website is a part of this joint initiative bringing together all information that is related to drug discovery and development or diagnostics from both universities.

Drug developmentand diagnostics

Research Groups and R&D Platforms: Biomarker, Breast cancer, Cancer, Data mining, Diagnostics, Genomics, Imaging, Molecular diagnostics, Next-generation sequencing, Pathology, Personalized medicine, Point of care

Research Group:Prognostic features in triple-negative breast carcinoma

Further information

Drug development
and diagnostics

Research Group:
Prognostic features in triple-negative breast carcinoma